1. Home
  2. ARDX vs AFYA Comparison

ARDX vs AFYA Comparison

Compare ARDX & AFYA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Ardelyx Inc.

ARDX

Ardelyx Inc.

HOLD

Current Price

$5.78

Market Cap

1.5B

Sector

Health Care

ML Signal

HOLD

Logo Afya Limited

AFYA

Afya Limited

HOLD

Current Price

$14.88

Market Cap

1.3B

Sector

Real Estate

ML Signal

HOLD

Company Overview

Basic Information
Metric
ARDX
AFYA
Founded
2007
1999
Country
United States
Brazil
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Other Consumer Services
Sector
Health Care
Real Estate
Exchange
Nasdaq
Nasdaq
Market Cap
1.5B
1.3B
IPO Year
2014
2019

Fundamental Metrics

Financial Performance
Metric
ARDX
AFYA
Price
$5.78
$14.88
Analyst Decision
Strong Buy
Buy
Analyst Count
10
4
Target Price
$10.65
$18.63
AVG Volume (30 Days)
2.7M
84.1K
Earning Date
10-30-2025
11-12-2025
Dividend Yield
N/A
1.55%
EPS Growth
N/A
25.39
EPS
N/A
1.50
Revenue
$398,234,000.00
$681,742,784.00
Revenue This Year
$22.77
$14.67
Revenue Next Year
$28.02
$7.89
P/E Ratio
N/A
$9.97
Revenue Growth
58.12
14.07
52 Week Low
$3.21
$13.47
52 Week High
$6.78
$19.90

Technical Indicators

Market Signals
Indicator
ARDX
AFYA
Relative Strength Index (RSI) 48.64 56.50
Support Level $5.63 $14.13
Resistance Level $6.04 $14.97
Average True Range (ATR) 0.24 0.31
MACD -0.02 0.02
Stochastic Oscillator 17.31 92.40

Price Performance

Historical Comparison
ARDX
AFYA

About ARDX Ardelyx Inc.

Ardelyx Inc is a biopharmaceutical company developing and commercialize, first-in-class medicines that meet unmet medical needs. It has developed a platform that enabled the discovery of new biological mechanisms and pathways to develop potent and efficacious therapies that minimize the side effects and drug-drug interactions frequently encountered with traditional, systemically absorbed medicines. It product Tenapanor, branded as IBSRELA, is used for the treatment of adults with IBS-C. Tenapanor, branded as XPHOZAH, is used to reduce serum phosphorus in adults with CKD on dialysis as add-on therapy in patients who have an inadequate response to phosphate binders or who are intolerant of any dose of phosphate binder therapy.

About AFYA Afya Limited

Afya Ltd is a medical education group based in Brazil. Its education portfolio has several courses in addition to Medicine, such as Management, Dentistry, Law, Engineering, Nursing, Psychology, and Accounting Sciences, among others. It has three segments; Undergrad provides educational services through undergraduate courses related to medical school, undergraduate health science and other ex-health undergraduate programs, Continuing Education provides medical education, specialization and graduate courses in medicine, delivered through digital and in-person content; and Medical practice solution provides clinical decision, clinical management and doctor-patient relationships for physicians and provide access, demand and efficiency for the healthcare players.

Share on Social Networks: